Impaired Tuning of Neural Ensembles and the Pathophysiology of Schizophrenia: A Translational and Computational Neuroscience Perspective

[1]  S. Grossberg.  Some normal and abnormal behavioral syndromes due to transmitter gating of opponent processes. , 1984, Biological psychiatry.

[2]  I Feinberg,et al.  Further evidence of abnormal non-rapid-eye-movement sleep in schizophrenia. , 1985, Archives of general psychiatry.

[3]  R. Hoffman.  Computer simulations of neural information processing and the schizophrenia-mania dichotomy. , 1987, Archives of general psychiatry.

[4]  D. O. Hebb,et al.  The organization of behavior , 1988 .

[5]  P. Goldman-Rakic,et al.  Prefrontal neuronal activity in rhesus monkeys performing a delayed anti-saccade task , 1993, Nature.

[6]  J. O’Keefe,et al.  Phase relationship between hippocampal place units and the EEG theta rhythm , 1993, Hippocampus.

[7]  R. Hoffman,et al.  Parallel distributed processing and the emergence of schizophrenic symptoms. , 1993, Schizophrenia bulletin.

[8]  E. Marder,et al.  Activity-dependent changes in the intrinsic properties of cultured neurons. , 1994, Science.

[9]  N. Cowan,et al.  Impaired precision, but normal retention, of auditory sensory ("echoic") memory information in schizophrenia. , 1997, Journal of abnormal psychology.

[10]  Bita Moghaddam,et al.  Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex , 1997, The Journal of Neuroscience.

[11]  P. Somogyi,et al.  Salient features of synaptic organisation in the cerebral cortex 1 Published on the World Wide Web on 3 March 1998. 1 , 1998, Brain Research Reviews.

[12]  Normal time course of auditory recognition in schizophrenia, despite impaired precision of the auditory sensory ("echoic") memory code. , 1999, Journal of abnormal psychology.

[13]  X. Wang,et al.  Synaptic Basis of Cortical Persistent Activity: the Importance of NMDA Receptors to Working Memory , 1999, The Journal of Neuroscience.

[14]  P. Goldman-Rakic,et al.  Isodirectional tuning of adjacent interneurons and pyramidal cells during working memory: evidence for microcolumnar organization in PFC. , 1999, Journal of neurophysiology.

[15]  I. Feinberg,et al.  Schizophrenia – a disorder of the corollary discharge systems that integrate the motor systems of thought with the sensory systems of consciousness , 1999, British Journal of Psychiatry.

[16]  P. Goldman-Rakic,et al.  Destruction and Creation of Spatial Tuning by Disinhibition: GABAA Blockade of Prefrontal Cortical Neurons Engaged by Working Memory , 2000, The Journal of Neuroscience.

[17]  S. Grossberg.  The imbalanced brain: from normal behavior to schizophrenia , 2000, Biological Psychiatry.

[18]  T. Sejnowski,et al.  Dopamine-mediated stabilization of delay-period activity in a network model of prefrontal cortex. , 2000, Journal of neurophysiology.

[19]  T. Freund,et al.  GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus , 2000, Neuroscience.

[20]  J. Krystal,et al.  Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists. , 2000, Archives of general psychiatry.

[21]  R. Coppola,et al.  Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. , 2000, Cerebral cortex.

[22]  Arne D. Ekstrom,et al.  NMDA Receptor Antagonism Blocks Experience-Dependent Expansion of Hippocampal “Place Fields” , 2001, Neuron.

[23]  J. Deakin,et al.  Augmenting antipsychotic treatment with lamotrigine or topiramate in patients with treatment-resistant schizophrenia: a naturalistic caseseries outcome study , 2001, Journal of psychopharmacology.

[24]  R. McCarley,et al.  Abnormal Neural Synchrony in Schizophrenia , 2003, The Journal of Neuroscience.

[25]  M. Monuteaux,et al.  Can adults with attention-deficit/hyperactivity disorder be distinguished from those with comorbid bipolar disorder? Findings from a sample of clinically referred adults , 2003, Biological Psychiatry.

[26]  J. Tiihonen,et al.  Lamotrigine in treatment-resistant schizophrenia: a randomized placebo-controlled crossover trial , 2003, Biological Psychiatry.

[27]  D. Cyril D’Souza,et al.  Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects , 2005, Psychopharmacology.

[28]  Xiao-Jing Wang,et al.  Effects of Neuromodulation in a Cortical Network Model of Object Working Memory Dominated by Recurrent Inhibition , 2004, Journal of Computational Neuroscience.

[29]  Matthew S. Cain,et al.  A failure of sleep-dependent procedural learning in chronic, medicated schizophrenia , 2004, Biological Psychiatry.

[30]  P. Goldman-Rakic,et al.  Division of labor among distinct subtypes of inhibitory neurons in a cortical microcircuit of working memory. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[31]  A. Belger,et al.  Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function. , 2005, Archives of general psychiatry.

[32]  D. Glahn,et al.  Beyond hypofrontality: A quantitative meta‐analysis of functional neuroimaging studies of working memory in schizophrenia , 2005, Human brain mapping.

[33]  Jozsef Csicsvari,et al.  Complementary Roles of Cholecystokinin- and Parvalbumin-Expressing GABAergic Neurons in Hippocampal Network Oscillations , 2005, The Journal of Neuroscience.

[34]  G. Buzsáki,et al.  Temporal Encoding of Place Sequences by Hippocampal Cell Assemblies , 2006, Neuron.

[35]  Bruce L McNaughton,et al.  Cannabinoids reveal importance of spike timing coordination in hippocampal function , 2006, Nature Neuroscience.

[36]  G. Davis.  Homeostatic control of neural activity: from phenomenology to molecular design. , 2006, Annual review of neuroscience.

[37]  S. Mosolov,et al.  Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial , 2007, Nature Medicine.

[38]  D. Goff,et al.  Lamotrigine as Add-On Therapy in Schizophrenia: Results of 2 Placebo-Controlled Trials , 2007, Journal of clinical psychopharmacology.

[39]  A. Anderson,et al.  Probing the pathophysiology of auditory/verbal hallucinations by combining functional magnetic resonance imaging and transcranial magnetic stimulation. , 2007, Cerebral cortex.

[40]  B. Moghaddam,et al.  NMDA Receptor Hypofunction Produces Opposite Effects on Prefrontal Cortex Interneurons and Pyramidal Neurons , 2007, The Journal of Neuroscience.

[41]  G. Tononi,et al.  Reduced sleep spindle activity in schizophrenia patients. , 2007, The American journal of psychiatry.

[42]  Xiao-Jing Wang,et al.  Cannabinoid-mediated disinhibition and working memory: dynamical interplay of multiple feedback mechanisms in a continuous attractor model of prefrontal cortex. , 2007, Cerebral cortex.

[43]  M. Poo,et al.  Spike-Timing-Dependent Plasticity of Neocortical Excitatory Synapses on Inhibitory Interneurons Depends on Target Cell Type , 2007, The Journal of Neuroscience.

[44]  G. Tononi,et al.  Molecular and electrophysiological evidence for net synaptic potentiation in wake and depression in sleep , 2008, Nature Neuroscience.

[45]  R. Mair,et al.  Memory Enhancement with Event-Related Stimulation of the Rostral Intralaminar Thalamic Nuclei , 2008, The Journal of Neuroscience.

[46]  D. Lewis,et al.  Neuroplasticity of Neocortical Circuits in Schizophrenia , 2008, Neuropsychopharmacology.

[47]  P. Goldman-Rakic,et al.  Impairment of Working Memory Maintenance and Response in Schizophrenia: Functional Magnetic Resonance Imaging Evidence , 2008, Biological Psychiatry.

[48]  D. Pinault,et al.  N-Methyl d-Aspartate Receptor Antagonists Ketamine and MK-801 Induce Wake-Related Aberrant γ Oscillations in the Rat Neocortex , 2008, Biological Psychiatry.

[49]  J. Gabrieli,et al.  Hyperactivity and hyperconnectivity of the default network in schizophrenia and in first-degree relatives of persons with schizophrenia , 2009, Proceedings of the National Academy of Sciences.

[50]  Wenjun Gao,et al.  Cell-type Specific Development of NMDA Receptors in the Interneurons of Rat Prefrontal Cortex , 2009, Neuropsychopharmacology.

[51]  K. Deisseroth,et al.  Parvalbumin neurons and gamma rhythms enhance cortical circuit performance , 2009, Nature.

[52]  P. Fletcher,et al.  Illusions and Delusions: Relating Experimentally-Induced False Memories to Anomalous Experiences and Ideas , 2009, Front. Behav. Neurosci..

[53]  György Buzsáki,et al.  Alteration of Theta Timescale Dynamics of Hippocampal Place Cells by a Cannabinoid Is Associated with Memory Impairment , 2009, The Journal of Neuroscience.

[54]  Valerie M. Beck,et al.  Reduced capacity but spared precision and maintenance of working memory representations in schizophrenia. , 2010, Archives of general psychiatry.

[55]  P. O’Donnell,et al.  Gamma and Delta Neural Oscillations and Association with Clinical Symptoms under Subanesthetic Ketamine , 2010, Neuropsychopharmacology.

[56]  Xiao-Jing Wang,et al.  Toward a neurobiology of delusions , 2010, Progress in Neurobiology.

[57]  G. Tononi,et al.  Sleep and synaptic renormalization: a computational study. , 2010, Journal of neurophysiology.

[58]  George Kirov,et al.  The role of copy number variation in schizophrenia , 2010, Expert review of neurotherapeutics.

[59]  E. Bullmore,et al.  Behavioral / Systems / Cognitive Functional Connectivity and Brain Networks in Schizophrenia , 2010 .

[60]  Joseph H Callicott,et al.  Genetic variation in CACNA1C affects brain circuitries related to mental illness. , 2010, Archives of general psychiatry.

[61]  György Buzsáki,et al.  Neural Syntax: Cell Assemblies, Synapsembles, and Readers , 2010, Neuron.

[62]  Jong H. Yoon,et al.  GABA Concentration Is Reduced in Visual Cortex in Schizophrenia and Correlates with Orientation-Specific Surround Suppression , 2010, The Journal of Neuroscience.

[63]  David A Lewis,et al.  Glutamate Receptor Subtypes Mediating Synaptic Activation of Prefrontal Cortex Neurons: Relevance for Schizophrenia , 2011, The Journal of Neuroscience.

[64]  A. Vita,et al.  Progressive loss of cortical gray matter in schizophrenia: a meta-analysis and meta-regression of longitudinal MRI studies , 2012, Translational Psychiatry.

[65]  Jordan P. Hamm,et al.  Augmented gamma band auditory steady-state responses: Support for NMDA hypofunction in schizophrenia , 2012, Schizophrenia Research.

[66]  Kenji Kirihara,et al.  Hierarchical Organization of Gamma and Theta Oscillatory Dynamics in Schizophrenia , 2012, Biological Psychiatry.

[67]  G. Barker,et al.  Ketamine effects on brain GABA and glutamate levels with 1H-MRS: relationship to ketamine-induced psychopathology , 2012, Molecular Psychiatry.

[68]  Jari Tiihonen,et al.  Exome sequencing followed by large-scale genotyping suggests a limited role for moderately rare risk factors of strong effect in schizophrenia. , 2012, American journal of human genetics.

[69]  Brendon O. Watson,et al.  Brain rhythms and neural syntax: implications for efficient coding of cognitive content and neuropsychiatric disease. , 2012, Dialogues in clinical neuroscience.

[70]  Xiao-Jing Wang,et al.  NMDA receptor function in large-scale anticorrelated neural systems with implications for cognition and schizophrenia , 2012, Proceedings of the National Academy of Sciences.

[71]  John-Dylan Haynes,et al.  Delusions and the role of beliefs in perceptual inference , 2012 .

[72]  L. Deserno,et al.  Reduced Prefrontal-Parietal Effective Connectivity and Working Memory Deficits in Schizophrenia , 2012, The Journal of Neuroscience.

[73]  Jessica A. Cardin,et al.  A critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction and behavior , 2011, Molecular Psychiatry.

[74]  J. Morrison,et al.  NMDA Receptors Subserve Persistent Neuronal Firing during Working Memory in Dorsolateral Prefrontal Cortex , 2013, Neuron.

[75]  Carl Baker,et al.  Support for the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia from exome sequencing in multiplex families. , 2013, JAMA psychiatry.

[76]  J. Lindenmayer,et al.  Pomaglumetad methionil: No significant difference as an adjunctive treatment for patients with prominent negative symptoms of schizophrenia compared to placebo , 2013, Schizophrenia Research.

[77]  M. Msall,et al.  Children with autism spectrum disorder and epilepsy. , 2013, Pediatric annals.

[78]  J. Lisman,et al.  The Theta-Gamma Neural Code , 2013, Neuron.

[79]  G. McCarthy,et al.  The Impact of NMDA Receptor Blockade on Human Working Memory-Related Prefrontal Function and Connectivity , 2013, Neuropsychopharmacology.

[80]  Peter R Luijten,et al.  Glutamate in schizophrenia: a focused review and meta-analysis of ¹H-MRS studies. , 2013, Schizophrenia bulletin.

[81]  A. Vercammen,et al.  Rethinking schizophrenia in the context of normal neurodevelopment , 2013, Front. Cell. Neurosci..

[82]  Progressive loss of cortical gray matter in schizophrenia: a meta-analysis and meta-regression of longitudinal MRI studies , 2013, Translational Psychiatry.

[83]  L. Siever,et al.  Spatial and Temporal Mapping of De Novo Mutations in Schizophrenia to a Fetal Prefrontal Cortical Network , 2013, Cell.

[84]  M. Scanziani,et al.  Inhibition of Inhibition in Visual Cortex: The Logic of Connections Between Molecularly Distinct Interneurons , 2013, Nature Neuroscience.

[85]  J. Krystal,et al.  Rapid-Acting Glutamatergic Antidepressants: The Path to Ketamine and Beyond , 2013, Biological Psychiatry.

[86]  G. McCarthy,et al.  Relationship of Resting Brain Hyperconnectivity and Schizophrenia-like Symptoms Produced by the NMDA receptor Antagonist Ketamine in Humans , 2012, Molecular Psychiatry.

[87]  Beatriz Paniagua,et al.  Imaging Patients with Psychosis and a Mouse Model Establishes a Spreading Pattern of Hippocampal Dysfunction and Implicates Glutamate as a Driver , 2013, Neuron.

[88]  Karl J. Friston,et al.  The Computational Anatomy of Psychosis , 2013, Front. Psychiatry.

[89]  Thomas M. Morse,et al.  Compartmentalization of GABAergic Inhibition by Dendritic Spines , 2013, Science.

[90]  George Dragoi,et al.  Development of schemas revealed by prior experience and NMDA receptor knock-out , 2013, eLife.

[91]  Paul Allen,et al.  Brain connectivity abnormalities predating the onset of psychosis: correlation with the effect of medication. , 2013, JAMA psychiatry.

[92]  Gina G. Turrigiano,et al.  How to Scale Down Postsynaptic Strength , 2013, The Journal of Neuroscience.

[93]  Wolf Singer,et al.  Evidence for dysregulated high-frequency oscillations during sensory processing in medication-naïve, first episode schizophrenia , 2013, Schizophrenia Research.

[94]  C. Stefanis,et al.  Indication of increased phase coupling between theta and gamma EEG rhythms associated with the experience of auditory verbal hallucinations , 2013, Neuroscience Letters.

[95]  S. Anderson,et al.  The chandelier cell, form and function , 2014, Current Opinion in Neurobiology.

[96]  A. Arnsten,et al.  Molecular influences on working memory circuits in dorsolateral prefrontal cortex. , 2014, Progress in molecular biology and translational science.

[97]  P. Kochunov,et al.  Neurodevelopmental and neurodegenerative models of schizophrenia: white matter at the center stage. , 2014, Schizophrenia bulletin.

[98]  C. Spencer,et al.  Biological Insights From 108 Schizophrenia-Associated Genetic Loci , 2014, Nature.

[99]  J. Isaacson,et al.  Single dendrite-targeting interneurons generate branch-specific inhibition , 2014, Front. Neural Circuits.

[100]  B. Kinon,et al.  Pomaglumetad Methionil (LY2140023 Monohydrate) and Aripiprazole in Patients with Schizophrenia: A Phase 3, Multicenter, Double-Blind Comparison , 2014, Schizophrenia research and treatment.

[101]  R. Gur,et al.  Parvalbumin Cell Ablation of NMDA-R1 Causes Increased Resting Network Excitability with Associated Social and Self-Care Deficits , 2014, Neuropsychopharmacology.

[102]  J. Rubenstein,et al.  Pyramidal Neurons in Prefrontal Cortex Receive Subtype-Specific Forms of Excitation and Inhibition , 2014, Neuron.

[103]  Danko D. Georgiev,et al.  Lower gene expression for KCNS3 potassium channel subunit in parvalbumin-containing neurons in the prefrontal cortex in schizophrenia. , 2014, The American journal of psychiatry.

[104]  Xiao-Jing Wang,et al.  Linking microcircuit dysfunction to cognitive impairment: effects of disinhibition associated with schizophrenia in a cortical working memory model. , 2014, Cerebral cortex.

[105]  Michael W. Cole,et al.  Altered global brain signal in schizophrenia , 2014, Proceedings of the National Academy of Sciences.

[106]  René S. Kahn,et al.  GABA and glutamate in schizophrenia: A 7 T 1H-MRS study , 2014, NeuroImage: Clinical.

[107]  W. Singer,et al.  Source-Reconstruction of Event-Related Fields Reveals Hyperfunction and Hypofunction of Cortical Circuits in Antipsychotic-Naive, First-Episode Schizophrenia Patients during Mooney Face Processing , 2014, The Journal of Neuroscience.

[108]  Xiao-Jing Wang,et al.  Erratum to: Effects of neuromodulation in a cortical network model of object working memory dominated by recurrent inhibition , 2014, Journal of Computational Neuroscience.

[109]  Roberto Hornero,et al.  Noise power associated with decreased task-induced variability of brain electrical activity in schizophrenia , 2016, European Archives of Psychiatry and Clinical Neuroscience.

[110]  B. Kinon,et al.  A double-blind, placebo-controlled comparator study of LY2140023 monohydrate in patients with schizophrenia , 2014, BMC Psychiatry.

[111]  Andrew C. Lin,et al.  Sparse, Decorrelated Odor Coding in the Mushroom Body Enhances Learned Odor Discrimination , 2014, Nature Neuroscience.

[112]  Yifeng Xu,et al.  Comparison of the density of gamma-aminobutyric acid in the ventromedial prefrontal cortex of patients with first-episode psychosis and healthy controls , 2015, Shanghai archives of psychiatry.

[113]  D. Weinberger,et al.  Investigation of the Prenatal Expression Patterns of 108 Schizophrenia-Associated Genetic Loci , 2015, Biological Psychiatry.

[114]  P. Nestor,et al.  Spontaneous Gamma Activity in Schizophrenia. , 2015, JAMA psychiatry.

[115]  J. Isaacson,et al.  Somatostatin-expressing interneurons provide subtractive inhibition and regulate sensory response fidelity in olfactory cortex , 2015, Nature Neuroscience.

[116]  Michael W. Cole,et al.  N-Methyl-D-Aspartate Receptor Antagonist Effects on Prefrontal Cortical Connectivity Better Model Early Than Chronic Schizophrenia , 2015, Biological Psychiatry.

[117]  A. Arnsten,et al.  Dopamine’s Actions in Primate Prefrontal Cortex: Challenges for Treating Cognitive Disorders , 2015, Pharmacological Reviews.

[118]  John H Krystal,et al.  Functional hierarchy underlies preferential connectivity disturbances in schizophrenia , 2015, Proceedings of the National Academy of Sciences.

[119]  E. Bullmore,et al.  Randomization and resilience of brain functional networks as systems-level endophenotypes of schizophrenia , 2015, Proceedings of the National Academy of Sciences.

[120]  Stephen V. David,et al.  Cortical Membrane Potential Signature of Optimal States for Sensory Signal Detection , 2015, Neuron.

[121]  Robert Freedman,et al.  Sensory processing dysfunction in the personal experience and neuronal machinery of schizophrenia. , 2015, The American journal of psychiatry.

[122]  H. Jörntell,et al.  Questioning the role of sparse coding in the brain , 2015, Trends in Neurosciences.

[123]  D. McKinzie,et al.  Exploratory Analysis for a Targeted Patient Population Responsive to the Metabotropic Glutamate 2/3 Receptor Agonist Pomaglumetad Methionil in Schizophrenia , 2015, Biological Psychiatry.

[124]  Rachel S White,et al.  Pyramidal Cell Selective Ablation of N-Methyl-D-Aspartate Receptor 1 Causes Increase in Cellular and Network Excitability , 2015, Biological Psychiatry.

[125]  A. Graff-Guerrero,et al.  Cortico-Striatal GABAergic and Glutamatergic Dysregulations in Subjects at Ultra-High Risk for Psychosis Investigated with Proton Magnetic Resonance Spectroscopy , 2015, The international journal of neuropsychopharmacology.

[126]  Jared X. Van Snellenberg,et al.  Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: a positron emission tomographic functional magnetic resonance imaging study. , 2015, JAMA psychiatry.

[127]  Wolf Singer,et al.  Ketamine Dysregulates the Amplitude and Connectivity of High-Frequency Oscillations in Cortical-Subcortical Networks in Humans: Evidence From Resting-State Magnetoencephalography-Recordings. , 2015, Schizophrenia bulletin.

[128]  K. Staley.  Molecular mechanisms of epilepsy , 2015, Nature Neuroscience.

[129]  G. Kirov,et al.  Novel Findings from CNVs Implicate Inhibitory and Excitatory Signaling Complexes in Schizophrenia , 2015, Neuron.

[130]  E. Sibille,et al.  Somatostatin, neuronal vulnerability and behavioral emotionality , 2014, Molecular Psychiatry.

[131]  Michael W. Cole,et al.  Early-Course Unmedicated Schizophrenia Patients Exhibit Elevated Prefrontal Connectivity Associated with Longitudinal Change , 2015, The Journal of Neuroscience.

[132]  Wolf Singer,et al.  Oscillations and Neuronal Dynamics in Schizophrenia: The Search for Basic Symptoms and Translational Opportunities , 2015, Biological Psychiatry.

[133]  J. Krystal,et al.  Toward Illness Phase–Specific Pharmacotherapy for Schizophrenia , 2015, Biological Psychiatry.

[134]  A. Sampson,et al.  Altered cortical expression of GABA-related genes in schizophrenia: illness progression vs developmental disturbance. , 2015, Schizophrenia bulletin.

[135]  T. Werge,et al.  15q13.3 homozygous knockout mouse model display epilepsy-, autism- and schizophrenia-related phenotypes , 2016, Translational Psychiatry.

[136]  Christian Tetzlaff,et al.  Opposing Effects of Neuronal Activity on Structural Plasticity , 2016, Front. Neuroanat..

[137]  BaDoi N. Phan,et al.  Psychiatric Risk Gene Transcription Factor 4 Regulates Intrinsic Excitability of Prefrontal Neurons via Repression of SCN10a and KCNQ1 , 2016, Neuron.

[138]  D. Weinberger,et al.  KCNH2-3.1 expression impairs cognition and alters neuronal function in a model of molecular pathology associated with schizophrenia , 2015, Molecular Psychiatry.

[139]  Paul G. Unschuld,et al.  Age-related changes in anterior cingulate cortex glutamate in schizophrenia: A 1H MRS Study at 7Tesla , 2016, Schizophrenia Research.

[140]  Edward E. Smith,et al.  Mechanisms of Working Memory Impairment in Schizophrenia , 2016, Biological Psychiatry.

[141]  Eric Hollander,et al.  Excitatory/inhibitory imbalance in autism spectrum disorders: Implications for interventions and therapeutics , 2016, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[142]  Peter Kochunov,et al.  Medial Frontal GABA is Lower in Older Schizophrenia: A MEGA-PRESS with Macromolecule Suppression Study , 2015, Molecular Psychiatry.

[143]  C. Lüscher,et al.  Hippocampal Somatostatin Interneurons Control the Size of Neuronal Memory Ensembles , 2016, Neuron.

[144]  L. Arckens,et al.  The Current Status of Somatostatin-Interneurons in Inhibitory Control of Brain Function and Plasticity , 2016, Neural plasticity.

[145]  Qi Xu,et al.  Genome-wide Analysis of the Role of Copy Number Variation in Schizophrenia Risk in Chinese , 2016, Biological Psychiatry.

[146]  Xiao-Jing Wang,et al.  A dendritic disinhibitory circuit mechanism for pathway-specific gating , 2016, Nature Communications.

[147]  Giulio Genovese,et al.  Schizophrenia risk from complex variation of complement component 4 , 2016, Nature.

[148]  A. Arnsten,et al.  Targeting Prefrontal Cortical Systems for Drug Development: Potential Therapies for Cognitive Disorders. , 2016, Annual review of pharmacology and toxicology.

[149]  K. Fish,et al.  Pathological Basis for Deficient Excitatory Drive to Cortical Parvalbumin Interneurons in Schizophrenia. , 2016, The American journal of psychiatry.

[150]  M. Kahana,et al.  Slow-Theta-to-Gamma Phase-Amplitude Coupling in Human Hippocampus Supports the Formation of New Episodic Memories. , 2016, Cerebral cortex.

[151]  M. O’Donovan,et al.  Comprehensive analysis of schizophrenia-associated loci highlights ion channel pathways and biologically plausible candidate causal genes. , 2016, Human molecular genetics.

[152]  Walter Paulus,et al.  Spatial Working Memory in Humans Depends on Theta and High Gamma Synchronization in the Prefrontal Cortex , 2016, Current Biology.

[153]  Alison L. Barth,et al.  Somatostatin-expressing neurons in cortical networks , 2016, Nature Reviews Neuroscience.

[154]  J. Pratt,et al.  Thalamo-cortical communication, glutamatergic neurotransmission and neural oscillations: A unique window into the origins of ScZ? , 2017, Schizophrenia Research.

[155]  R. Mailman,et al.  Novel Dopamine Therapeutics for Cognitive Deficits in Schizophrenia , 2017, Biological Psychiatry.

[156]  Xiao-Jing Wang,et al.  Schizophrenia is associated with a pattern of spatial working memory deficits consistent with cortical disinhibition , 2017, Schizophrenia Research.

[157]  Gil D. Hoftman,et al.  Layer 3 Excitatory and Inhibitory Circuitry in the Prefrontal Cortex: Developmental Trajectories and Alterations in Schizophrenia , 2017, Biological Psychiatry.